SYS6020

· CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SYS6020, covering 2024-11-19 to 2024-11-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SYS6020 Injection in Refractory Active Systemic Lupus Erythematosus [Phase 1]